Latest Financial Health News

Kingston Resources Limited reported a robust cash position of A$31 million at the end of September 2025, supported by significant investing inflows and prudent financing activity.

JB Hi-Fi Limited reported robust FY25 results with double-digit sales growth and a leadership transition, while outlining ambitious plans for FY26 focused on expansion and sustainability.

PentaNet Ltd reported a positive net operating cash flow of A$594,000 in the September 2025 quarter, bolstered by strong liquidity and ongoing investment in 5G infrastructure.

Hot Chili Limited has successfully raised A$14.1 million through a fully subscribed entitlement offer to advance its Costa Fuego copper-gold project in Chile, initiating a critical second phase of diamond drilling at the La Verde discovery.

Adisyn Ltd has strengthened its position in semiconductor innovation by commissioning a cutting-edge Atomic Layer Deposition system, accelerating its graphene interconnect development while maintaining a robust cash reserve.

Alchemy Resources Limited reported a net cash outflow in Q3 2025 but strengthened its financial position by securing $750,000 through a new agreement with Newcam Minerals Ltd.

Rand Mining Ltd has announced a fully franked dividend of 10 cents per share, reinforcing its commitment to regular shareholder returns while maintaining financial prudence.

Tribune Resources has announced a fully franked dividend of 20 cents per share, signalling confidence in its financial position while maintaining cautious discretion for future payouts.

Stelar Metals is actively negotiating new project acquisitions across critical minerals while implementing cost-cutting measures to safeguard its cash position of $2.3 million at the end of September 2025.

Ark Mines Ltd reported a significant cash burn in the September quarter, prompting a $500,000 capital raise and plans to secure $4 million from a royalty sale to sustain operations.

Associate Global Partners Limited reported a 4.6% increase in funds under management to $1.464 billion for Q3 2025, driven by robust inflows and standout returns from its WCM strategies. The company also sustained positive operating cash flows for the fourth consecutive quarter.

BlinkLab has completed its U.S. autism pilot study with strong diagnostic accuracy and expanded its pivotal FDA trial to seven leading research centers, positioning itself for regulatory submission in late 2026.